Donna Neuberg

Title: Donna Neuberg: Innovator in Myelodysplastic Syndrome Research

Introduction

Donna Neuberg is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of medical research, particularly in the area of myelodysplastic syndrome. With a total of 2 patents, her work focuses on improving treatment outcomes for patients suffering from this condition.

Latest Patents

One of her latest patents is titled "Methods for determining response to a hypomethylating agent." This patent discloses methods for predicting a subject's response to treatment with a hypomethylating agent, utilizing samples obtained from the subject. The methods are designed to select subjects for treatment and measure their response to therapy, as well as monitor disease progression or regression. Another significant patent is "Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects." This patent highlights that somatic non-silent mutations on selected biomarkers serve as reliable indicators for the overall survival of patients with myelodysplastic syndrome.

Career Highlights

Throughout her career, Donna Neuberg has worked with esteemed institutions such as Dana-Farber Cancer Institute and Brigham and Women's Hospital. Her research has been pivotal in advancing the understanding and treatment of myelodysplastic syndrome.

Collaborations

She has collaborated with notable colleagues, including Rafael Bejar and Benjamin L. Ebert, further enhancing the impact of her research in the medical community.

Conclusion

Donna Neuberg's innovative work in the field of myelodysplastic syndrome has the potential to significantly improve patient outcomes. Her patents and collaborations reflect her dedication to advancing medical research and treatment methodologies.